Inhibitors of heat shock protein 70 (Hsp70) with enhanced metabolic stability reduce tau levels

[Display omitted] •Two series of YM-08 analogs were designed to remove metabolic liabilities.•Optimization resulted in JG-23, which is 12-fold more metabolically stable.•Compound JG-23 reduced total tau in two cell-based models. The molecular chaperone, Heat Shock Protein 70 (Hsp70), is an emerging...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 41; p. 128025
Main Authors Shao, Hao, Li, Xiaokai, Hayashi, Shigenari, Bertron, Jeanette L., Schwarz, Daniel M.C., Tang, Benjamin C., Gestwicki, Jason E.
Format Journal Article
LanguageEnglish
Published OXFORD Elsevier Ltd 01.06.2021
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] •Two series of YM-08 analogs were designed to remove metabolic liabilities.•Optimization resulted in JG-23, which is 12-fold more metabolically stable.•Compound JG-23 reduced total tau in two cell-based models. The molecular chaperone, Heat Shock Protein 70 (Hsp70), is an emerging drug target for neurodegenerative diseases, because of its ability to promote degradation of microtubule-associated protein tau (MAPT/tau). Recently, we reported YM-08 as a brain penetrant, allosteric Hsp70 inhibitor, which reduces tau levels. However, the benzothiazole moiety of YM-08 is vulnerable to metabolism by CYP3A4, limiting its further application as a chemical probe. In this manuscript, we designed and synthesized seventeen YM-08 derivatives by systematically introducing halogen atoms to the benzothiazole ring and shifting the position of the heteroatom in a distal pyridine. In microsome assays, we found that compound JG-23 has 12-fold better metabolic stability and it retained the ability to reduce tau levels in two cell-based models. These chemical probes of Hsp70 are expected to be useful tools for studying tau homeostasis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2021.128025